Anika Therapeutics logo
Anika Therapeutics ANIK
$ 17.32 2.3%

Квартальный отчет 2024-Q3
добавлен 04.11.2024

report update icon

Anika Therapeutics Мультипликаторы 2011-2025 | ANIK

Мультипликаторы по годам Anika Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-4.5 -27.3 110.8 -21.9 22.3 29.3 31.2 22.4 18.3 15.0 22.9 12.0 14.0

P/S

2.2 2.6 3.1 4.0 5.3 5.2 8.8 7.1 6.0 5.4 6.3 2.0 1.8

EPS

-5.6 -1.0 0.3 -1.7 1.9 1.3 2.2 2.2 2.1 2.6 1.5 0.9 0.7

EV (Enterprise Value)

300 млн 319 млн 364 млн 431 млн 491 млн 474 млн 880 млн 643 млн 476 млн 491 млн 429 млн 130 млн 121 млн

EBITDA per Share

-5.54 -0.87 0.63 -1.56 2.85 1.92 3.43 3.7 3.48 4.51 2.63 2.02 1.38

EV/EBITDA

38.7 -429.8 11.2 16.6 17.2 11.5 8.7 7.2 11.0 4.0 5.2

PEG

-0.43 0.26 -1.86 0.73 0.46 -0.72 -17.34 2.89 -0.87 0.19 0.36 0.33 0.15

P/B

1.4 1.2 1.3 1.4 2.1 2.1 3.8 3.3 2.7 3.2 3.5 1.3 1.3

P/CF

-208.5 92.0 54.5 40.3 17.7 18.1 31.2 74.6 18.8 15.0 19.1 15.6 13.6

ROE %

-38.95 -5.20 1.44 -8.80 9.43 7.10 12.07 14.61 14.59 21.52 15.17 10.79 8.93

ROA %

-30.55 -4.26 1.19 -6.56 8.22 6.71 11.26 13.55 13.05 19.75 13.19 8.28 6.37

ROCE %

-41.29 -6.79 0.91 -10.40 10.89 8.12 16.97 21.87 22.03 32.68 22.02 17.44 11.81

Current Ratio

- - - - 14.4 18.3 15.8 19.4 10.2 23.3 10.2 5.4 4.4

DSO

77.3 75.3 66.6 66.0 73.5 71.8 76.7 97.4 85.0 59.3 91.1 109.8 97.5

DIO

247.3 220.7 231.4 202.6 279.3 293.3 293.9 242.8 259.0 216.4 176.3 104.3 99.5

DPO

54.4 48.7 46.8 38.1 48.7 36.7 90.0 35.0 143.9 20.9 44.8 29.5 58.6

Операционный цикл

324.6 296.0 298.0 268.6 352.8 365.1 370.6 340.2 344.0 275.6 267.4 214.1 197.0

Финансовый цикл

270.2 247.3 251.2 230.6 304.1 328.4 280.6 305.3 200.0 254.7 222.6 184.6 138.4
P/E
P/S
EV/EBITDA
PEG
P/B
P/CF
ROE %
ROA %
ROCE %
Current Ratio
DSO
DIO
DPO
20232023202220222021202120202020201920192018201820172017201620162015201520142014201320132012201220112011400 400 200 200 0 0 -200 -200 -400 -400 -600 -600
Download SVG
Download PNG
Download CSV

Все данные представлены в валюте USD

Мультипликаторы поквартально Anika Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-2.03 -0.01 -0.31 - -0.45 -0.19 -0.71 - -0.29 -0.2 -0.2 - 0.04 0.45 0.2 -1.1 -0.45 -0.54 0.41 0.28 0.65 0.68 0.32 0.54 0.53 0.69 -0.46 0.55 0.47 0.78 0.38 0.56 0.61 0.59 0.46 0.74 0.56 0.52 0.24 0.53 0.42 0.63 1.04 0.47 0.36 0.44 0.23 0.33 0.12 0.28 0.15 0.22 0.23 0.18 0.03

EBITDA per Share

-1.88 0.04 -0.23 - -0.39 -0.11 -0.75 - -0.06 -0.1 -0.13 - 0.42 0.78 0.2 - -0.24 -0.22 0.69 - 1.17 1.07 0.49 - 0.91 0.97 -0.43 - 0.93 1.35 0.62 - 1.13 1.05 0.78 - 1.06 0.95 0.43 - 0.94 1.2 1.73 - 0.83 0.86 0.46 - 0.46 0.63 0.31 - 0.61 0.44 0.12

ROE %

-21.27 -7.07 -8.03 -7.16 -8.63 -7.66 -7.65 -3.49 -3.29 -1.64 1.64 3.50 -2.25 -4.80 -9.91 -8.80 -1.65 3.89 9.99 9.43 10.95 10.64 11.20 7.10 7.24 6.97 7.45 12.07 12.64 14.05 13.60 14.61 16.22 16.17 16.02 14.59 13.74 13.23 14.74 21.52 22.03 22.22 21.35 15.17 14.36 12.22 11.30 10.79 9.74 11.37 10.35 8.93 3.14 2.41 0.34

ROA %

-14.67 -2.58 -3.38 -4.72 -5.09 -6.29 -6.31 -2.91 -2.76 -0.54 1.26 2.74 -1.54 -3.45 -7.36 -6.56 -1.05 3.48 8.44 8.22 9.76 9.71 10.47 6.71 6.80 6.51 6.92 11.26 11.77 13.06 12.62 13.55 14.87 14.69 14.43 13.05 12.42 12.04 13.52 19.78 19.99 19.98 18.97 13.19 12.06 10.04 8.90 8.28 7.30 8.39 7.48 6.37 2.24 1.72 0.24

ROCE %

-20.77 -8.03 -9.43 -8.68 -10.72 -9.92 -9.77 -4.46 -4.01 -1.53 2.85 4.10 1.19 -2.16 -8.87 -3.81 0.37 7.46 15.09 10.21 13.46 12.54 12.67 4.55 8.44 9.09 11.55 13.66 19.81 22.06 21.37 17.00 23.23 23.31 23.16 14.73 20.51 20.06 22.70 27.71 33.44 33.39 31.78 16.35 18.85 15.63 14.33 10.95 16.03 18.61 16.86 9.55 5.08 3.88 0.59

Current Ratio

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

73.2 71.7 76.6 - - 69.4 36.9 - - - 37.1 - 71.3 66.9 67.3 67.3 69.4 71.7 60.8 70.7 70.9 69.2 80.9 70.3 70.8 62.1 95.7 74.0 80.0 65.0 100.3 87.7 97.7 94.7 100.8 64.0 83.4 86.3 114.1 67.3 71.0 59.6 48.1 80.5 96.3 82.1 120.3 86.6 132.6 99.8 123.2 85.6 85.6 97.8 -

DIO

111.4 316.2 275.0 - - 249.8 245.3 - 97.2 108.6 218.3 - 215.2 225.3 304.6 - 293.8 249.0 219.1 232.1 337.3 293.6 270.2 277.6 234.7 238.4 252.0 230.7 321.7 318.4 285.1 - - - - - - - - - - - - - - - - - - - - - - - -

DPO

20.5 62.7 57.1 - - 50.3 54.5 - 21.8 23.0 46.2 - 44.3 44.2 60.5 - 57.1 48.4 41.2 40.4 58.8 51.1 43.5 41.0 34.6 35.2 57.5 70.6 98.5 97.5 67.9 - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

184.5 387.9 275.0 - - 319.1 282.2 - 97.2 108.6 255.4 - 286.5 292.2 372.0 67.3 363.2 320.7 279.9 302.8 408.2 362.8 351.1 347.9 305.4 300.5 347.7 304.7 401.7 383.4 385.5 87.7 97.7 94.7 100.8 64.0 83.4 86.3 114.1 67.3 71.0 59.6 48.1 80.5 96.3 82.1 120.3 86.6 132.6 99.8 123.2 85.6 85.6 97.8 -

Финансовый цикл

164.0 325.1 217.9 - - 268.9 227.6 - 75.4 85.7 209.2 - 242.1 248.0 311.5 67.3 306.1 272.2 238.8 262.4 349.4 311.7 307.6 307.0 270.8 265.3 290.2 234.0 303.2 285.9 317.6 87.7 97.7 94.7 100.8 64.0 83.4 86.3 114.1 67.3 71.0 59.6 48.1 80.5 96.3 82.1 120.3 86.6 132.6 99.8 123.2 85.6 85.6 97.8 -
P/E
P/S
EPS
EV/EBITDA
PEG
P/B
P/CF
ROE %
ROA %
ROCE %
Current Ratio
DSO
DIO
DPO
20232023202220222021202120202020201920192018201820172017201620162015201520142014201320132012201220112011400 400 200 200 0 0 -200 -200 -400 -400 -600 -600
Download SVG
Download PNG
Download CSV

Все данные представлены в валюте USD